Author

Udeme Ohia

Observed names: U Ohia, U. Ohia

Institutions: Alder Hey Children's NHS Foundation Trust, Alder Hey Children's Hospital

Observed institutions: University Hospitals Birmingham NHS Foundation Trust, Public Health England, National Institute for Health and Care Research, University of Oxford, Alder Hey Children's NHS Foundation Trust, Public Health Scotland, National Records of Scotland, Nepal Health Research Council, Oxford University Clinical Research Unit, Alder Hey Children's Hospital, Intensive Care National Audit & Research Centre, Oxford University Clinical Research Unit Indonesia

OpenAlex ID: A5084126812

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 560

PDF

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 504

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 390

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 302

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia

2021 · Julia A. Bielicki, Wolfgang Stöhr, et al. · JAMA · 121

PDF

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 41

PDF

Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT))

2020 · Louise Bracken, Emma McDonough, et al. · BMJ Open · 39

PDF

Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People

2022 · Louise Bracken, Rober Habashy, et al. · Pharmaceutics · 33

PDF

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2024 · RECOVERY Collaborative Group, Peter Sandercock, et al. · Nature Communications · 11

PDF

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer

2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5

O23 Can children swallow tablets? outcome data from a feasibility study to assess the swallowability and acceptability of different sized placebo tablets in children and young people (creating acceptable tablets – cat)

2019 · L Bracken, E McDonough, et al. · Archives of Disease in Childhood · 3

PDF

Acceptability of minitablets in soft food. A randomised cross-over study in children

2026 · Jennifer C. Duncan, Rebecca Page, et al. · Frontiers in Pharmacology · 2

PDF

Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial

2026 · Malcolm G Semple, Chloe Donohue, et al. · The Lancet Respiratory Medicine · 1

SP8 Creating acceptable tablets 3D (CAT 3D): a feasibility study to evaluate the mouthfeel of 3D printed tablets in children and young people

2020 · Louise Bracken, Emma McDonough, et al. · Archives of Disease in Childhood

PDF

P001 Creating acceptable tablets (CAT) – a feasibility study to assess the swallowability and acceptability of different sized placebo tablets in children and young people: an interim analysis

2019 · Louise Bracken, Emma McDonough, et al. · Archives of Disease in Childhood

PDF

Works count: 15

Citation count: 2,012

H-index: 9

I10-index: 9